Abbas Tafakhori

Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial

Mona Ahmadi, Elmira Agah, Shahriar Nafissi et al. · Neurotherapeutics · 2018 · 142 citations · Full text

Life Sciences, Neurology, Neuroscience +16

The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients

Mina Abdolahi, Abbas Tafakhori, Mansoureh Togha et al. · Immunogenetics · 2017 · 108 citations

Life Sciences, Immunology, Nutritional Sciences +17

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

Morteza Jafarinia, Mohsen Afarideh, Abbas Tafakhori et al. · Journal of Affective Disorders · 2016 · 98 citations

Nursing, Pharmacology, Pharmacotherapy +14

Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial

Somaye Arabzadeh, Elham Hakki-Kazazi, Nazila Shahmansouri et al. · Journal of Affective Disorders · 2018 · 90 citations

Medicine, Pharmacology, Psychiatry +16

The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms

Mina Abdolahi, Arash Jafarieh, Payam Sarraf et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 2019 · 89 citations

Life Sciences, Nutritional Sciences, Pharmacology +17